Yüklüyor......
Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond
Myelofibrosis (MF) is a heterogeneous disorder characterized by splenomegaly, constitutional symptoms, ineffective hematopoiesis, and an inherent risk of leukemic transformation. The past decade has seen a massive shift in available therapeutic options for our patients and we are learning how and wh...
Kaydedildi:
| Yayımlandı: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142531/ https://ncbi.nlm.nih.gov/pubmed/29222297 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|